7
Views
32
CrossRef citations to date
0
Altmetric
Article

Regulation of Acetylation at the Major Histocompatibility Complex Class II Proximal Promoter by the 19S Proteasomal ATPase Sug1

, , , , , & show all
Pages 5837-5850 | Received 02 Apr 2008, Accepted 07 Jul 2008, Published online: 27 Mar 2023

REFERENCES

  • Adamski, J., Z. Ma, S. Nozell, and E. N. Benveniste. 2004. 17β-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter. Mol. Endocrinol. 18:1963–1974.
  • Agalioti, T., G. Chen, and D. Thanos. 2002. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111:381–392.
  • Alarcon-Vargas, D., and Z. Ronai. 2002. p53-Mdm2—the affair that never ends. Carcinogenesis 23:541–547.
  • Athanassiou, M., Y. Hu, L. Jing, B. Houle, H. Zarbl, and A. M. Mikheev. 1999. Stabilization and reactivation of the p53 tumor suppressor protein in nontumorigenic revertants of HeLa cervical cancer cells. Cell Growth Differ. 10:729–737.
  • Auld, K. L., C. R. Brown, J. M. Casolari, S. Komili, and P. A. Silver. 2006. Genomic association of the proteasome demonstrates overlapping gene regulatory activity with transcription factor substrates. Mol. Cell 21:861–871.
  • Bannister, A. J., and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641–643.
  • Baumeister, W., J. Walz, F. Zuhl, and E. Seemuller. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367–380.
  • Beresford, G. W., and J. M. Boss. 2001. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nat. Immunol. 2:652–657.
  • Bernstein, B. E., M. Kamal, K. Lindblad-Toh, S. Bekiranov, D. K. Bailey, D. J. Huebert, S. McMahon, E. K. Karlsson, E. J. Kulbokas III, T. R. Gingeras, S. L. Schreiber, and E. S. Lander. 2005. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120:169–181.
  • Bhat, K. P., J. D. Turner, S. E. Myers, A. D. Cape, J. P. Ting, and S. F. Greer. 2008. The 19S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription. Mol. Immunol. 45:2214–2224.
  • Bhaumik, S. R., T. Raha, D. P. Aiello, and M. R. Green. 2004. In vivo target of a transcriptional activator revealed by fluorescence resonance energy transfer. Genes Dev. 18:333–343.
  • Boss, J. M., and P. E. Jensen. 2003. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr. Opin. Immunol. 15:105–111.
  • Buschmann, T., O. Potapova, A. Bar-Shira, V. N. Ivanov, S. Y. Fuchs, S. Henderson, V. A. Fried, T. Minamoto, D. Alarcon-Vargas, M. R. Pincus, W. A. Gaarde, N. J. Holbrook, Y. Shiloh, and Z. Ronai. 2001. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21:2743–2754.
  • Carey, M., and S. T. Smale. 2000. Transcriptional regulation in eukaryotes. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  • Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363–2373.
  • Chou, S. D., and T. B. Tomasi. 2008. Spatial distribution of histone methylation during MHC class II expression. Mol. Immunol. 45:971–980.
  • Ciechanover, A. 1998. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17:7151–7160.
  • Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79:13–21.
  • Close, P., N. Hawkes, I. Cornez, C. Creppe, C. A. Lambert, B. Rogister, U. Siebenlist, M. P. Merville, S. A. Slaugenhaupt, V. Bours, J. Q. Svejstrup, and A. Chariot. 2006. Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol. Cell 22:521–531.
  • Collins, G. A., and W. P. Tansey. 2006. The proteasome: a utility tool for transcription? Curr. Opin. Genet. Dev. 16:197–202.
  • Conaway, R. C., C. S. Brower, and J. W. Conaway. 2002. Emerging roles of ubiquitin in transcription regulation. Science 296:1254–1258.
  • Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801–847.
  • Daniel, J. A., and P. A. Grant. 2007. Multi-tasking on chromatin with the SAGA coactivator complexes. Mutat. Res. 618:135–148.
  • Eberharter, A., and P. B. Becker. 2002. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 3:224–229.
  • Ezhkova, E., and W. P. Tansey. 2004. Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. Mol. Cell 13:435–442.
  • Ferdous, A., F. Gonzalez, L. Sun, T. Kodadek, and S. A. Johnston. 2001. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell 7:981–991.
  • Ferdous, A., T. Kodadek, and S. A. Johnston. 2002. A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II. Biochemistry 41:12798–12805.
  • Fish, J. E., C. C. Matouk, A. Rachlis, S. Lin, S. C. Tai, C. D'Abreo, and P. A. Marsden. 2005. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J. Biol. Chem. 280:24824–24838.
  • Fontes, J. D., S. Kanazawa, D. Jean, and B. M. Peterlin. 1999. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell. Biol. 19:941–947.
  • Francis, J., S. K. Chakrabarti, J. C. Garmey, and R. G. Mirmira. 2005. Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription. J. Biol. Chem. 280:36244–36253.
  • Freiman, R. N., and R. Tjian. 2003. Regulating the regulators: lysine modifications make their mark. Cell 112:11–17.
  • Gerloni, M., and M. Zanetti. 2005. CD4 T cells in tumor immunity. Springer Semin. Immunopathol. 27:37–48.
  • Gillette, T. G., F. Gonzalez, A. Delahodde, S. A. Johnston, and T. Kodadek. 2004. Physical and functional association of RNA polymerase II and the proteasome. Proc. Natl. Acad. Sci. USA 101:5904–5909.
  • Glickman, M. H., D. M. Rubin, H. Fu, C. N. Larsen, O. Coux, I. Wefes, G. Pfeifer, Z. Cjeka, R. Vierstra, W. Baumeister, V. Fried, and D. Finley. 1999. Functional analysis of the proteasome regulatory particle. Mol. Biol. Rep. 26:21–28.
  • Gomez, J. A., P. Majumder, U. M. Nagarajan, and J. M. Boss. 2005. X box-like sequences in the MHC class II region maintain regulatory function. J. Immunol. 175:1030–1040.
  • Gonzalez, F., A. Delahodde, T. Kodadek, and S. A. Johnston. 2002. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296:548–550.
  • Gorisch, S. M., M. Wachsmuth, K. F. Toth, P. Lichter, and K. Rippe. 2005. Histone acetylation increases chromatin accessibility. J. Cell Sci. 118:5825–5834.
  • Greer, S. F., E. Zika, B. Conti, X. S. Zhu, and J. P. Ting. 2003. Enhancement of CIITA transcriptional function by ubiquitin. Nat. Immunol. 4:1074–1082.
  • Hawkes, N. A., G. Otero, G. S. Winkler, N. Marshall, M. E. Dahmus, D. Krappmann, C. Scheidereit, C. L. Thomas, G. Schiavo, H. Erdjument-Bromage, P. Tempst, and J. Q. Svejstrup. 2002. Purification and characterization of the human elongator complex. J. Biol. Chem. 277:3047–3052.
  • Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293:1074–1080.
  • Kanazawa, S., T. Okamoto, and B. M. Peterlin. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12:61–70.
  • Kim, J. H., W. S. Lane, and D. Reinberg. 2002. Human Elongator facilitates RNA polymerase II transcription through chromatin. Proc. Natl. Acad. Sci. USA 99:1241–1246.
  • Kretsovali, A., T. Agalioti, C. Spilianakis, E. Tzortzakaki, M. Merika, and J. Papamatheakis. 1998. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell. Biol. 18:6777–6783.
  • Laribee, R. N., Y. Shibata, D. P. Mersman, S. R. Collins, P. Kemmeren, A. Roguev, J. S. Weissman, S. D. Briggs, N. J. Krogan, and B. D. Strahl. 2007. CCR4/NOT complex associates with the proteasome and regulates histone methylation. Proc. Natl. Acad. Sci. USA 104:5836–5841.
  • Lassot, I., D. Latreille, E. Rousset, M. Sourisseau, L. K. Linares, C. Chable-Bessia, O. Coux, M. Benkirane, and R. E. Kiernan. 2007. The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms. Mol. Cell 25:369–383.
  • Lee, D., E. Ezhkova, B. Li, S. G. Pattenden, W. P. Tansey, and J. L. Workman. 2005. The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell 123:423–436.
  • Liang, G., J. C. Lin, V. Wei, C. Yoo, J. C. Cheng, C. T. Nguyen, D. J. Weisenberger, G. Egger, D. Takai, F. A. Gonzales, and P. A. Jones. 2004. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc. Natl. Acad. Sci. USA 101:7357–7362.
  • Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301–331.
  • Martens, J. H., M. Verlaan, E. Kalkhoven, and A. Zantema. 2003. Cascade of distinct histone modifications during collagenase gene activation. Mol. Cell. Biol. 23:1808–1816.
  • Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J. C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:273–277.
  • Masternak, K., N. Peyraud, M. Krawczyk, E. Barras, and W. Reith. 2003. Chromatin remodeling and extragenic transcription at the MHC class II locus control region. Nat. Immunol. 4:132–137.
  • McVean, M., H. Xiao, K. Isobe, and J. C. Pelling. 2000. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis 21:633–639.
  • Morris, A. C., G. W. Beresford, M. R. Mooney, and J. M. Boss. 2002. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation. Mol. Cell. Biol. 22:4781–4791.
  • Morris, M. C., P. Kaiser, S. Rudyak, C. Baskerville, M. H. Watson, and S. I. Reed. 2003. Cks1-dependent proteasome recruitment and activation of CDC20 transcription in budding yeast. Nature 423:1009–1013.
  • Muratani, M., and W. P. Tansey. 2003. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4:192–201.
  • Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953–959.
  • Parham, P. 2005. The immune system. Garland Science, New York, NY.
  • Pavri, R., B. Zhu, G. Li, P. Trojer, S. Mandal, A. Shilatifard, and D. Reinberg. 2006. Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell 125:703–717.
  • Pokholok, D. K., C. T. Harbison, S. Levine, M. Cole, N. M. Hannett, T. I. Lee, G. W. Bell, K. Walker, P. A. Rolfe, E. Herbolsheimer, J. Zeitlinger, F. Lewitter, D. K. Gifford, and R. A. Young. 2005. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122:517–527.
  • Rasti, M., R. J. Grand, A. F. Yousef, M. Shuen, J. S. Mymryk, P. H. Gallimore, and A. S. Turnell. 2006. Roles for APIS and the 20S proteasome in adenovirus E1A-dependent transcription. EMBO J. 25:2710–2722.
  • Roth, S. Y., J. M. Denu, and C. D. Allis. 2001. Histone acetyltransferases. Annu. Rev. Biochem. 70:81–120.
  • Rubin, D. M., O. Coux, I. Wefes, C. Hengartner, R. A. Young, A. L. Goldberg, and D. Finley. 1996. Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome. Nature 379:655–657.
  • Rybtsova, N., E. Leimgruber, Q. Seguin-Estevez, I. Dunand-Sauthier, M. Krawczyk, and W. Reith. 2007. Transcription-coupled deposition of histone modifications during MHC class II gene activation. Nucleic Acids Res. 35:3431–3441.
  • Schiltz, R. L., C. A. Mizzen, A. Vassilev, R. G. Cook, C. D. Allis, and Y. Nakatani. 1999. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem. 274:1189–1192.
  • Schubeler, D., D. M. MacAlpine, D. Scalzo, C. Wirbelauer, C. Kooperberg, F. van Leeuwen, D. E. Gottschling, L. P. O'Neill, B. M. Turner, J. Delrow, S. P. Bell, and M. Groudine. 2004. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 18:1263–1271.
  • Shilatifard, A. 2006. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 75:243–269.
  • Sikder, D., S. A. Johnston, and T. Kodadek. 2006. Widespread, but non-identical, association of proteasomal 19 and 20 S proteins with yeast chromatin. J. Biol. Chem. 281:27346–27355.
  • Spilianakis, C., A. Kretsovali, T. Agalioti, T. Makatounakis, D. Thanos, and J. Papamatheakis. 2003. CIITA regulates transcription onset via Ser5-phosphorylation of RNA Pol II. EMBO J. 22:5125–5136.
  • Strickland, E., K. Hakala, P. J. Thomas, and G. N. DeMartino. 2000. Recognition of misfolding proteins by PA700, the regulatory subcomplex of the 26 S proteasome. J. Biol. Chem. 275:5565–5572.
  • Sulahian, R., D. Sikder, S. A. Johnston, and T. Kodadek. 2006. The proteasomal ATPase complex is required for stress-induced transcription in yeast. Nucleic Acids Res. 34:1351–1357.
  • Sun, Z. W., and C. D. Allis. 2002. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature 418:104–108.
  • Swaffield, J. C., K. Melcher, and S. A. Johnston. 1995. A highly conserved ATPase protein as a mediator between acidic activation domains and the TATA-binding protein. Nature 374:88–91.
  • Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68:1015–1068.
  • vom Baur, E., C. Zechel, D. Heery, M. J. Heine, J. M. Garnier, V. Vivat, B. Le Douarin, H. Gronemeyer, P. Chambon, and R. Losson. 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15:110–124.
  • Wesierska-Gadek, J., D. Schloffer, V. Kotala, and M. Horky. 2002. Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy. Int. J. Cancer 101:128–136.
  • Wright, K. L., and J. P. Ting. 2006. Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol. 27:405–412.
  • Yu, P., and T. Kodadek. 2007. Dynamics of the hypoxia-inducible factor-1-vascular endothelial growth factor promoter complex. J. Biol. Chem. 282:35035–35045.
  • Zhu, Q., G. Wani, J. Yao, S. Patnaik, Q. E. Wang, M. A. El-Mahdy, M. Praetorius-Ibba, and A. A. Wani. 2007. The ubiquitin-proteasome system regulates p53-mediated transcription at p21(waf1) promoter. Oncogene 26:4199–4208.
  • Zhu, X. S., and J. P. Ting. 2001. A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen α2(I) and other promoters. Mol. Cell. Biol. 21:7078–7088.
  • Zika, E., L. Fauquier, L. Vandel, and J. P. Ting. 2005. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression. Proc. Natl. Acad. Sci. USA 102:16321–16326.
  • Zika, E., S. F. Greer, X. S. Zhu, and J. P. Ting. 2003. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Mol. Cell. Biol. 23:3091–3102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.